Riarify

formoterol fumarate dihydrate; glycopyrronium; beclometasone dipropionate · Chiesi Farmaceutici S.p.A.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Riarify, covering 2025-03-18 to 2025-03-18. Get the full timeline:

Most recent: EMA Withdrawn: Riarify (previously CHF 5993 Chiesi Farmaceutici S.p.A.) (formoterol fumarate dihydrate;glycopyrronium;beclometasone dipropionate) — Chiesi Farmaceutici S.p.A.

See pricing